11 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
, reputational harm and diminished profits and future earnings. POINT is subject to complex and extensive laws and regulations, including those related … in federal and state healthcare programs, individual imprisonment, reputational harm, and the curtailment or restructuring of its operations, as well
424B3
PNT
POINT Biopharma Global Inc.
31 Mar 22
Prospectus supplement
11:42am
damages, reputational harm and diminished profits and future earnings.
POINT is subject to complex and extensive laws and regulations, including those … programs, individual imprisonment, reputational harm, and the curtailment or restructuring of its operations, as well as additional reporting
POS AM
PNT
POINT Biopharma Global Inc.
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
expose POINT to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.
POINT … , disgorgement, the exclusion from participation in federal and state healthcare programs, individual imprisonment, reputational harm, and the curtailment
424B3
PNT
POINT Biopharma Global Inc.
5 Aug 21
Prospectus supplement
4:26pm
and regulations, which could expose POINT to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future … , fines, disgorgement, the exclusion from participation in federal and state healthcare programs, individual imprisonment, reputational harm
424B3
6txlrwizougc orl
9 Jun 21
Prospectus supplement
4:42pm
S-4/A
kt4vy77
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
sf404d0s3htsgxdrsot
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
- Prev
- 1
- Next